Cheelcare (TSXV: CHER) has reported earnings for its fourth quarter and fiscal year ending April 30, 2026. In an Aug. 31 update, the Markham, Ontario-based manufacturer said fiscal 2026 revenue was up 22% to $1.9 million CAD (approximately $1.372 million U.S.). Cheelcare said it sold 536 Companion power-assist systems for the year, compared to 453…
Cheelcare Announces Q4 Earnings, Curio PWC Update
Ekso Bionics ‘Working to Get Back on Track’ After Lower Second-Quarter Earnings Report
The exoskeleton company also shared possible application expansions, including use by clients with neurodegenerative diagnoses.
Ekso Bionics (Nasdaq: EKSO), manufacturer of the Ekso Indego Personal exoskeleton, reported lower revenue numbers for its second quarter in a July 28 earnings call. “While there was abnormal weakness in the second quarter, in large part due to what we believe are short-term delays in completing some multi-device enterprise health sales, we are working…
Ekso Bionics Q1 Earnings: Partnerships with NSM, Bionic P&O Expected to Grow Personal Health Products Segment This Year
National Seating & Mobility was announced as the exclusive CRT distributor of the Ekso Indego Personal exoskeleton in February.
New partnerships with national Complex Rehab Technology (CRT) and prosthetics/orthotics providers are expected to grow Ekso Bionics’ Personal Health Products segment for 2025, the company announced during its May 5 earnings call. Ekso Bionics (Nasdaq: EKSO) reported earnings results for the three months ending on March 31, 2025, while also commenting on what the company…